References
Gust L, Taieb D, Beliard A, et al. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors. World J Surg. 2012;36(6):1406–10.
Mackie GC, Shulkin BL, Ribeiro RC, et al. Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. 2006;91(7):2665–71.
Blake MA, Prakash P, Cronin CG. PET/CT for adrenal assessment. AJR Am J Roentgenol. 2010;195(2):W91–5.
Leboulleux S, Dromain C, Bonniaud G, et al. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab. 2006;91(3):920–5.
Wong KK, Arabi M, Zerizer I, et al. Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers. Nucl Med Commun. 2011;32(9):764–81.
Ahmed M, Al-Sugair A, Alarifi A, et al. Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures. Clin Nucl Med. 2003;28(6):494–7.
Blake MA, Cronin CG, Boland GW. Adrenal imaging. AJR Am J Roentgenol. 2010;194(6):1450–60.
Avram AM, Fig LM, Gross MD. Adrenal gland scintigraphy. Semin Nucl Med. 2006;36(3):212–27.
Horne T, Glaser B, Krausz Y, et al. Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med. 1991;16(4):239–42.
Letizia C, De Toma G, Massa R, et al. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Investig. 1998;21(11):779–83.
Rainis T, Ben-Haim S, Dickstein G. False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma. J Clin Endocrinol Metab. 2000;85(1):5–7.
Acknowledgments
The authors declare no acknowledgments of assistance and were not in possession of grants or other funding for this work.
Conflict of Interest
Cristina Rodríguez Rey, Aída Ortega Candil, Eliseo Vañó Galván, María Nieves Cabrera Martín and José Luis Carreras Delgado declare that they have no conflicts of interest.
Ethical Statement
The authors referred this case to the President of the Ethical Committee of their Hospital prior to writing this report. She declared that it was not necessary to request a written informed consent from the patient because the patient had already been informed verbally that the case could be published. The President of the Ethical Committee also considered that the case accords with the 1964 Declaration of Helsinki.
Not Published Before
The authors declare that the content of this manuscript has not been published before and is not under consideration for publication anywhere else.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodríguez Rey, C., Ortega Candil, A., Vañó Galván, E. et al. Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan. Nucl Med Mol Imaging 50, 166–168 (2016). https://doi.org/10.1007/s13139-015-0343-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-015-0343-3